ADVERTISEMENT
Purdue Pharma L.P. is now selling Intermezzo, an insomnia drug designed to help people fall back asleep after waking up in the middle of the night.
The drug is formulated as a spearmint-flavored tablet that dissolves under the tongue.
The U.S. Food and Drug Administration approved Intermezzo last November. The drug was developed by Point Richmond, Calif.-based Transcept Pharmaceuticals Inc., which in 2009 licensed North American marketing rights to Purdue.
It is Stamford-based Purdue Pharma”™s first new drug release since Butrans, used to alleviate pain in patients who require around-the-clock care.
